Royal Bank of Canada’s Histogen Inc. Common Stock HSTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-15
| Closed | – | – | 7919 |
|
|
2023
Q3 | $0 | Hold |
15
| – | – | ﹤0.01% | 7983 |
|
|
2023
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 8010 |
|
|
2023
Q1 | $0 | Hold |
15
| – | – | ﹤0.01% | 7865 |
|
|
2022
Q4 | $0 | Sell |
15
-3
| -17% | -$3 | ﹤0.01% | 8213 |
|
|
2022
Q3 | $0 | Buy |
18
+3
| +20% | +$7 | ﹤0.01% | 8270 |
|
|
2022
Q2 | $0 | Hold |
15
| – | – | ﹤0.01% | 8184 |
|
|
2022
Q1 | $0 | Buy |
+15
| New | +$76 | ﹤0.01% | 8260 |
|
|
2021
Q3 | – | Sell |
-5
| Closed | – | – | 8084 |
|
|
2021
Q2 | $0 | Buy |
+5
| New | +$104 | ﹤0.01% | 7874 |
|
|
2021
Q1 | – | Sell |
-50
| Closed | -$1K | – | 7839 |
|
|
2020
Q4 | $1K | Buy |
+50
| New | +$1.56K | ﹤0.01% | 7008 |
|
|
2018
Q4 | – | Sell |
-4
| Closed | -$4K | – | 7317 |
|
|
2018
Q3 | $4K | Buy |
+4
| New | +$3.69K | ﹤0.01% | 6369 |
|
|
2018
Q2 | – | Sell |
-8
| Closed | -$9K | – | 6890 |
|
|
2018
Q1 | $9K | Buy |
8
+2
| +33% | +$2.21K | ﹤0.01% | 5770 |
|
|
2017
Q4 | $6K | Sell |
6
-10
| -63% | -$9.23K | ﹤0.01% | 6048 |
|
|
2017
Q3 | $17K | Buy |
16
+10
| +167% | +$11.4K | ﹤0.01% | 6044 |
|
|
2017
Q2 | $6K | Buy |
6
+1
| +20% | +$1.22K | ﹤0.01% | 6000 |
|
|
2017
Q1 | $6K | Buy |
+5
| New | +$4.83K | ﹤0.01% | 6166 |
|
|
2013
Q4 | – | Sell |
-1
| Closed | -$2K | – | 6228 |
|
|
2013
Q3 | $2K | Buy |
+1
| New | +$1.86K | ﹤0.01% | 5884 |
|
Other funds holding HSTO
Royal Bank of Canada's HSTO Position: Q4 2023 in Review
Royal Bank of Canada sold out of Histogen Inc. Common Stock (HSTO) in Q4 2023, closing a stake of 15 shares.
Royal Bank of Canada first reported a position in HSTO in Q3 2013 and held it in 16 quarters. The position peaked at $17K in Q3 2017. 1 fund tracked by Wall St. Rank holds HSTO as of Q4 2023.
- Royal Bank of Canada reported no remaining Histogen Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- Royal Bank of Canada sold 15 Histogen Inc. Common Stock shares in Q4 2023.
- Royal Bank of Canada first reported a position in Histogen Inc. Common Stock in Q3 2013 and held it in 16 quarters.
- Royal Bank of Canada's Histogen Inc. Common Stock position peaked at $17K in Q3 2017.
- 1 fund tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q4 2023.
Based on Royal Bank of Canada's 13F filing for Q4 2023, filed 14 Feb 2024.